LMG Life Sciences recognizes Hogan Lovells as Regulatory Firm of the Year for third year in a row 2020
Hogan Lovells is pleased to announce that it scored three major wins at the LMG Life Sciences eighth annual awards event, including being named Regulatory Firm of the Year for a third straight year. In addition, Beth Roberts was named Regulatory Attorney of the Year; Pricing & Reimbursement, and partner David Fox was inducted into the LMG Life Sciences Hall of Fame. These awards emphasize the firm’s top rankings in the United States across all regulatory areas named by LMG Life Sciences.
Hogan Lovells has had a noteworthy year of regulatory work advising major clients on FDA clearance, pricing and reimbursement, and post-approval enforcement. The firm was notably active for many clients in matters resulting from the Covid-19 pandemic, assisting them in obtaining Emergency Use Authorizations for products like ventilators and face masks that were critical to the global response to the health crisis.
LMG Life Sciences editor Chris Adams said of the winners: “Our research team has found Hogan Lovells to be one of the strongest regulatory practices from top to bottom, and is a worthy winner of the Regulatory Firm award for the third year in a row. The group has all areas covered that LMG Life Sciences looks for in a full-service practice, and standout attorneys to boot. We also found the honor fitting due to Hogan Lovells’ activity for several key clients responding to the Covid-19 pandemic with essential products and technologies.
David Fox’s induction into the Hall of Fame emphasizes his status as an FDA advisor at the top of his game. He is an attorney we know to be well-respected in the life sciences industry, and is deserving of the honor. Beth Roberts continues to be a star in pricing and reimbursement matters, showcased through her precedent-setting work for coverage of important cell therapies.”
As part of their research, clients told LMG Life Sciences that Hogan Lovells is “Highly strategic, highly engaged”, “[Has] depth of bench and able to manage multiple issues”, and “Hogan takes a much more collaborative approach, which I prefer.”
In addition to the final winners, Hogan Lovells was also a Firm of the Year finalist in Government Investigations and Life Cycle categories. Individually, seven partners were finalists for Attorney of the Year recognitions including, David Fox (Regulatory: Pharmaceutical), Mike Heyl (Regulatory: Medical Device), Asher Rubin (Corporate), Adam Golden (Licensing & Collaboration), Michael Theis (Government Investigations), James Johnson (U.S. Rising Star – Regulatory), and Adriana Tibbitts (U.S. Rising Star – Finance & Corporate).
To view the full list of winners, or read about the process and methodology, please visit LMGLifeSciencesAwards.com.